Pharmacokinetics of Intravenously and Intraperitoneally Administered Mafedine Sodium in Mice
Peculiarities of the pharmacokinetics of mafedine sodium salt upon intraperitoneal (i.p.) and intravenous (i.v.) administration to laboratory mice were studied. A high-performance liquid chromatography (HPLC) method for its quantitative determination was proposed. Mafedine sodium salt was found to h...
Gespeichert in:
Veröffentlicht in: | Pharmaceutical chemistry journal 2021-03, Vol.54 (12), p.1193-1197 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1197 |
---|---|
container_issue | 12 |
container_start_page | 1193 |
container_title | Pharmaceutical chemistry journal |
container_volume | 54 |
creator | Sysoev, Yu. I. Whaley, A. K. Prikhodko, V. A. Semivelichenko, E. D. Eletskaya, E. I. Luzhanin, V. G. Okovityi, S. V. |
description | Peculiarities of the pharmacokinetics of mafedine sodium salt upon intraperitoneal (i.p.) and intravenous (i.v.) administration to laboratory mice were studied. A high-performance liquid chromatography (HPLC) method for its quantitative determination was proposed. Mafedine sodium salt was found to have a short biological elimination half-life after both i.p. and i.v. administration (15.73 and 6.98 min, respectively) and high i.p. bioavailability (~94%). Features of the alpha-2-adrenomimetic activity of mafedine sodium salt could be elucidated by further searches for and investigations of its metabolites and their pharmacokinetics. |
doi_str_mv | 10.1007/s11094-021-02342-y |
format | Article |
fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A656116735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A656116735</galeid><sourcerecordid>A656116735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-27260b809dc5c4355ecaa8214c0901c1178f604c1275e097d9aa44946b1d4c5f3</originalsourceid><addsrcrecordid>eNp9kFtLAzEQhYMoWKt_wKcFn1dnNsleHkvxUmhRUMEHIaRJtqbuZkuyFfbfG11fBJFhGDicb5g5hJwjXCJAcRUQoWIpZBibsiwdDsgEeUHTCigekglAhSlyeDkmJyFsASJGswl5fXiTvpWqe7fO9FaFpKuTheu9_DCu24dmSKTTo7Iz3vadM7KJ6ky31tnQG290spK10XFB8thpu28T65KVVeaUHNWyCebsZ07J88310_wuXd7fLuazZaooL_s0K7Ic1iVUWnHFKOdGSVlmyBRUgAqxKOscmMKs4AaqQldSMlaxfI2aKV7TKbkY925kY4R1dRevVa0NSsxyniPmBeXRdfmHK5Y2rVXxr9pG_ReQjYDyXQje1GLnbSv9IBDEV-xijF3E2MV37GKIEB2hEM1uY7zYdnvv4vv_UZ-Z24Vu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacokinetics of Intravenously and Intraperitoneally Administered Mafedine Sodium in Mice</title><source>Springer Journals</source><creator>Sysoev, Yu. I. ; Whaley, A. K. ; Prikhodko, V. A. ; Semivelichenko, E. D. ; Eletskaya, E. I. ; Luzhanin, V. G. ; Okovityi, S. V.</creator><creatorcontrib>Sysoev, Yu. I. ; Whaley, A. K. ; Prikhodko, V. A. ; Semivelichenko, E. D. ; Eletskaya, E. I. ; Luzhanin, V. G. ; Okovityi, S. V.</creatorcontrib><description>Peculiarities of the pharmacokinetics of mafedine sodium salt upon intraperitoneal (i.p.) and intravenous (i.v.) administration to laboratory mice were studied. A high-performance liquid chromatography (HPLC) method for its quantitative determination was proposed. Mafedine sodium salt was found to have a short biological elimination half-life after both i.p. and i.v. administration (15.73 and 6.98 min, respectively) and high i.p. bioavailability (~94%). Features of the alpha-2-adrenomimetic activity of mafedine sodium salt could be elucidated by further searches for and investigations of its metabolites and their pharmacokinetics.</description><identifier>ISSN: 0091-150X</identifier><identifier>EISSN: 1573-9031</identifier><identifier>DOI: 10.1007/s11094-021-02342-y</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Dexmedetomidine ; High performance liquid chromatography ; Medicine ; Mice ; Molecular-Biological Problems of Drug Design and Mechanism of Drug Action ; Organic Chemistry ; Pharmacology/Toxicology ; Pharmacy</subject><ispartof>Pharmaceutical chemistry journal, 2021-03, Vol.54 (12), p.1193-1197</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>COPYRIGHT 2021 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-27260b809dc5c4355ecaa8214c0901c1178f604c1275e097d9aa44946b1d4c5f3</citedby><cites>FETCH-LOGICAL-c358t-27260b809dc5c4355ecaa8214c0901c1178f604c1275e097d9aa44946b1d4c5f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11094-021-02342-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11094-021-02342-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Sysoev, Yu. I.</creatorcontrib><creatorcontrib>Whaley, A. K.</creatorcontrib><creatorcontrib>Prikhodko, V. A.</creatorcontrib><creatorcontrib>Semivelichenko, E. D.</creatorcontrib><creatorcontrib>Eletskaya, E. I.</creatorcontrib><creatorcontrib>Luzhanin, V. G.</creatorcontrib><creatorcontrib>Okovityi, S. V.</creatorcontrib><title>Pharmacokinetics of Intravenously and Intraperitoneally Administered Mafedine Sodium in Mice</title><title>Pharmaceutical chemistry journal</title><addtitle>Pharm Chem J</addtitle><description>Peculiarities of the pharmacokinetics of mafedine sodium salt upon intraperitoneal (i.p.) and intravenous (i.v.) administration to laboratory mice were studied. A high-performance liquid chromatography (HPLC) method for its quantitative determination was proposed. Mafedine sodium salt was found to have a short biological elimination half-life after both i.p. and i.v. administration (15.73 and 6.98 min, respectively) and high i.p. bioavailability (~94%). Features of the alpha-2-adrenomimetic activity of mafedine sodium salt could be elucidated by further searches for and investigations of its metabolites and their pharmacokinetics.</description><subject>Dexmedetomidine</subject><subject>High performance liquid chromatography</subject><subject>Medicine</subject><subject>Mice</subject><subject>Molecular-Biological Problems of Drug Design and Mechanism of Drug Action</subject><subject>Organic Chemistry</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><issn>0091-150X</issn><issn>1573-9031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kFtLAzEQhYMoWKt_wKcFn1dnNsleHkvxUmhRUMEHIaRJtqbuZkuyFfbfG11fBJFhGDicb5g5hJwjXCJAcRUQoWIpZBibsiwdDsgEeUHTCigekglAhSlyeDkmJyFsASJGswl5fXiTvpWqe7fO9FaFpKuTheu9_DCu24dmSKTTo7Iz3vadM7KJ6ky31tnQG290spK10XFB8thpu28T65KVVeaUHNWyCebsZ07J88310_wuXd7fLuazZaooL_s0K7Ic1iVUWnHFKOdGSVlmyBRUgAqxKOscmMKs4AaqQldSMlaxfI2aKV7TKbkY925kY4R1dRevVa0NSsxyniPmBeXRdfmHK5Y2rVXxr9pG_ReQjYDyXQje1GLnbSv9IBDEV-xijF3E2MV37GKIEB2hEM1uY7zYdnvv4vv_UZ-Z24Vu</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Sysoev, Yu. I.</creator><creator>Whaley, A. K.</creator><creator>Prikhodko, V. A.</creator><creator>Semivelichenko, E. D.</creator><creator>Eletskaya, E. I.</creator><creator>Luzhanin, V. G.</creator><creator>Okovityi, S. V.</creator><general>Springer US</general><general>Springer</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210301</creationdate><title>Pharmacokinetics of Intravenously and Intraperitoneally Administered Mafedine Sodium in Mice</title><author>Sysoev, Yu. I. ; Whaley, A. K. ; Prikhodko, V. A. ; Semivelichenko, E. D. ; Eletskaya, E. I. ; Luzhanin, V. G. ; Okovityi, S. V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-27260b809dc5c4355ecaa8214c0901c1178f604c1275e097d9aa44946b1d4c5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Dexmedetomidine</topic><topic>High performance liquid chromatography</topic><topic>Medicine</topic><topic>Mice</topic><topic>Molecular-Biological Problems of Drug Design and Mechanism of Drug Action</topic><topic>Organic Chemistry</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sysoev, Yu. I.</creatorcontrib><creatorcontrib>Whaley, A. K.</creatorcontrib><creatorcontrib>Prikhodko, V. A.</creatorcontrib><creatorcontrib>Semivelichenko, E. D.</creatorcontrib><creatorcontrib>Eletskaya, E. I.</creatorcontrib><creatorcontrib>Luzhanin, V. G.</creatorcontrib><creatorcontrib>Okovityi, S. V.</creatorcontrib><collection>CrossRef</collection><jtitle>Pharmaceutical chemistry journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sysoev, Yu. I.</au><au>Whaley, A. K.</au><au>Prikhodko, V. A.</au><au>Semivelichenko, E. D.</au><au>Eletskaya, E. I.</au><au>Luzhanin, V. G.</au><au>Okovityi, S. V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics of Intravenously and Intraperitoneally Administered Mafedine Sodium in Mice</atitle><jtitle>Pharmaceutical chemistry journal</jtitle><stitle>Pharm Chem J</stitle><date>2021-03-01</date><risdate>2021</risdate><volume>54</volume><issue>12</issue><spage>1193</spage><epage>1197</epage><pages>1193-1197</pages><issn>0091-150X</issn><eissn>1573-9031</eissn><abstract>Peculiarities of the pharmacokinetics of mafedine sodium salt upon intraperitoneal (i.p.) and intravenous (i.v.) administration to laboratory mice were studied. A high-performance liquid chromatography (HPLC) method for its quantitative determination was proposed. Mafedine sodium salt was found to have a short biological elimination half-life after both i.p. and i.v. administration (15.73 and 6.98 min, respectively) and high i.p. bioavailability (~94%). Features of the alpha-2-adrenomimetic activity of mafedine sodium salt could be elucidated by further searches for and investigations of its metabolites and their pharmacokinetics.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s11094-021-02342-y</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-150X |
ispartof | Pharmaceutical chemistry journal, 2021-03, Vol.54 (12), p.1193-1197 |
issn | 0091-150X 1573-9031 |
language | eng |
recordid | cdi_gale_infotracmisc_A656116735 |
source | Springer Journals |
subjects | Dexmedetomidine High performance liquid chromatography Medicine Mice Molecular-Biological Problems of Drug Design and Mechanism of Drug Action Organic Chemistry Pharmacology/Toxicology Pharmacy |
title | Pharmacokinetics of Intravenously and Intraperitoneally Administered Mafedine Sodium in Mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T09%3A10%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20of%20Intravenously%20and%20Intraperitoneally%20Administered%20Mafedine%20Sodium%20in%20Mice&rft.jtitle=Pharmaceutical%20chemistry%20journal&rft.au=Sysoev,%20Yu.%20I.&rft.date=2021-03-01&rft.volume=54&rft.issue=12&rft.spage=1193&rft.epage=1197&rft.pages=1193-1197&rft.issn=0091-150X&rft.eissn=1573-9031&rft_id=info:doi/10.1007/s11094-021-02342-y&rft_dat=%3Cgale_cross%3EA656116735%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A656116735&rfr_iscdi=true |